SK286902B6 - Inhibítory faktora VIIa, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje - Google Patents

Inhibítory faktora VIIa, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje Download PDF

Info

Publication number
SK286902B6
SK286902B6 SK1759-2001A SK17592001A SK286902B6 SK 286902 B6 SK286902 B6 SK 286902B6 SK 17592001 A SK17592001 A SK 17592001A SK 286902 B6 SK286902 B6 SK 286902B6
Authority
SK
Slovakia
Prior art keywords
group
alkyl
carbon atoms
het
aryl
Prior art date
Application number
SK1759-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK17592001A3 (sk
Inventor
Otmar Klingler
Manfred Schudok
Gerhard Zoller
Uwe Heinelt
Elisabeth Defossa
Hans Matter
Pavel Safar
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of SK17592001A3 publication Critical patent/SK17592001A3/sk
Publication of SK286902B6 publication Critical patent/SK286902B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1759-2001A 1999-06-08 2000-05-27 Inhibítory faktora VIIa, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje SK286902B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99111109A EP1059302A1 (fr) 1999-06-08 1999-06-08 Inhibiteurs de factor VIIa
PCT/EP2000/004846 WO2000075172A2 (fr) 1999-06-08 2000-05-27 INHIBITEURS DU FACTEUR VIIa

Publications (2)

Publication Number Publication Date
SK17592001A3 SK17592001A3 (sk) 2002-05-09
SK286902B6 true SK286902B6 (sk) 2009-07-06

Family

ID=8238315

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1759-2001A SK286902B6 (sk) 1999-06-08 2000-05-27 Inhibítory faktora VIIa, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje

Country Status (32)

Country Link
US (1) US6500803B1 (fr)
EP (2) EP1059302A1 (fr)
JP (1) JP4546683B2 (fr)
KR (1) KR100979069B1 (fr)
CN (1) CN1359390B (fr)
AR (1) AR024292A1 (fr)
AT (1) ATE246707T1 (fr)
AU (1) AU774037B2 (fr)
BR (1) BR0011461A (fr)
CA (1) CA2376064C (fr)
CZ (1) CZ300365B6 (fr)
DE (1) DE60004363T2 (fr)
DK (1) DK1189929T3 (fr)
EE (1) EE04855B1 (fr)
ES (1) ES2202137T3 (fr)
HK (1) HK1047289B (fr)
HR (1) HRP20010912B1 (fr)
HU (1) HUP0201451A3 (fr)
IL (2) IL146731A0 (fr)
ME (1) MEP57708A (fr)
MX (1) MXPA01012568A (fr)
NO (1) NO328249B1 (fr)
NZ (1) NZ515966A (fr)
PL (1) PL202879B1 (fr)
PT (1) PT1189929E (fr)
RS (1) RS50415B (fr)
RU (1) RU2248359C2 (fr)
SI (1) SI1189929T1 (fr)
SK (1) SK286902B6 (fr)
TR (1) TR200103550T2 (fr)
WO (1) WO2000075172A2 (fr)
ZA (1) ZA200110053B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1059302A1 (fr) * 1999-06-08 2000-12-13 Aventis Pharma Deutschland GmbH Inhibiteurs de factor VIIa
DE10005631A1 (de) * 2000-02-09 2001-08-23 Max Planck Gesellschaft Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
WO2002062829A1 (fr) * 2001-02-02 2002-08-15 Chugai Seiyaku Kabushiki Kaisha Derives de peptide
GB0127615D0 (en) * 2001-07-09 2002-01-09 Aventis Pharm Prod Inc Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
AU2004265021B2 (en) 2003-08-18 2010-05-27 H. Lundbeck A/S Succinate and malonate salt of trans-4-(IR,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
TWI376373B (en) 2005-02-16 2012-11-11 Lundbeck & Co As H Crystalline base of a pharmaceutical compound
TWI453198B (zh) 2005-02-16 2014-09-21 Lundbeck & Co As H 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
WO2007002313A2 (fr) * 2005-06-24 2007-01-04 Bristol-Myers Squibb Company Derives de phenylglycinamide et pyridylglycinamide utiles en tant que anticoagulants
WO2007131996A1 (fr) * 2006-05-12 2007-11-22 Genmedica Therapeutics Sl Sels de vanadate de méta-xylylène diamine
JP2019525947A (ja) 2016-06-01 2019-09-12 エムスリー・バイオテクノロジー・インコーポレイテッドＭ３ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． 化合物
CA3145453A1 (fr) 2019-07-01 2021-01-07 Tonix Pharma Limited Anticorps anti-cd154 et leurs utilisations
JP2024503625A (ja) 2021-01-06 2024-01-26 トニックス ファーマ リミテッド 改変された抗ｃｄ１５４抗体により免疫寛容を誘導する方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023236A (en) * 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
US5506134A (en) 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
KR100380124B1 (ko) * 1994-04-26 2003-08-02 셀렉타이드 코포레이션 인자Xa억제제
DK0892780T3 (da) * 1996-02-22 2003-03-03 Bristol Myers Squibb Pharma Co m-Amidinophenylanaloger som faktor Xa-inhibitorer
AR013084A1 (es) * 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
EP0987274A1 (fr) * 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Inhibiteurs du facteur VIIa
EP1059302A1 (fr) * 1999-06-08 2000-12-13 Aventis Pharma Deutschland GmbH Inhibiteurs de factor VIIa

Also Published As

Publication number Publication date
MXPA01012568A (es) 2002-04-10
EP1189929B1 (fr) 2003-08-06
KR20020020728A (ko) 2002-03-15
CZ300365B6 (cs) 2009-04-29
ATE246707T1 (de) 2003-08-15
IL146731A (en) 2007-07-24
HUP0201451A3 (en) 2003-08-28
JP4546683B2 (ja) 2010-09-15
NO20016005D0 (no) 2001-12-07
EP1059302A1 (fr) 2000-12-13
WO2000075172A3 (fr) 2001-05-31
SI1189929T1 (en) 2004-02-29
WO2000075172A2 (fr) 2000-12-14
ES2202137T3 (es) 2004-04-01
DE60004363T2 (de) 2004-06-24
NO328249B1 (no) 2010-01-18
DE60004363D1 (de) 2003-09-11
CN1359390A (zh) 2002-07-17
US6500803B1 (en) 2002-12-31
RU2248359C2 (ru) 2005-03-20
CA2376064C (fr) 2011-04-26
HK1047289A1 (en) 2003-02-14
AR024292A1 (es) 2002-09-25
TR200103550T2 (tr) 2002-05-21
NZ515966A (en) 2003-09-26
HRP20010912B1 (en) 2010-10-31
PL202879B1 (pl) 2009-07-31
EE04855B1 (et) 2007-06-15
PL352200A1 (en) 2003-08-11
CN1359390B (zh) 2010-05-26
AU5397600A (en) 2000-12-28
CA2376064A1 (fr) 2000-12-14
BR0011461A (pt) 2002-03-19
IL146731A0 (en) 2002-07-25
SK17592001A3 (sk) 2002-05-09
HRP20010912A2 (en) 2003-04-30
NO20016005L (no) 2002-02-06
DK1189929T3 (da) 2003-11-24
RS50415B (sr) 2009-12-31
EP1189929A2 (fr) 2002-03-27
HK1047289B (zh) 2010-10-22
PT1189929E (pt) 2003-12-31
ZA200110053B (en) 2002-07-03
AU774037B2 (en) 2004-06-17
MEP57708A (en) 2011-05-10
HUP0201451A2 (en) 2002-08-28
CZ20014357A3 (cs) 2002-03-13
JP2003502294A (ja) 2003-01-21
EE200100662A (et) 2003-04-15
YU86101A (sh) 2004-07-15
KR100979069B1 (ko) 2010-08-31

Similar Documents

Publication Publication Date Title
RU2286337C2 (ru) ПРОИЗВОДНЫЕ (ТИО)МОЧЕВИНЫ, ИНГИБИРУЮЩИЕ ФАКТОР VIIa, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
US6794365B2 (en) Malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them
CZ20012379A3 (cs) Nové deriváty malonové kyseliny, způsoby jejich přípravy, použití a farmaceutické přípravky obsahující tyto deriváty (inhibitory aktivity faktoru Xa)
SK286902B6 (sk) Inhibítory faktora VIIa, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje
JP4658430B2 (ja) Ｎ−グアニジノアルキルアミド、その製造、その使用およびそれを含む医薬調製物
JP5016178B2 (ja) 抗血栓活性を有するマロンアミドおよびマロンアミド酸エステル誘導体、それらの製造および使用
JP2002534408A (ja) アリールアルカノイル誘導体、その調製のための方法、その使用およびそれらを含有する医薬組成物
US20030109547A1 (en) Amidinophenylpyruvic acid derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130527